Biomerica Q1 EPS $(0.37), Sales $1.265M Down From $1.380M YoY

8-K filing — BIOMERICA INC (BMRA)

Filed: 2026-10-15 AccNo: 0001493152-26-047270 Size: 198 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Biomerica Files $250M Shelf Registration Statement For Mixed Securities Offering

BIOMERICA, INC. $250,000,000 Common StockPreferred StockDebt SecuritiesWarrants We may offer and sell the securities identified above from time to time in one or more offerings, in amounts, at prices and on terms

Biomerica Files Prospectus Covering Resale Of Up To 1,403,705 Shares Of Common Stock By Selling Stockholders

BIOMERICA, INC. 1,403,705 Shares of Common Stock This prospectus relates to the proposed resale or other disposition by the selling stockholders identified in this prospectus of up to 1,403,705 shares of our common

Biomerica Q4 EPS $(0.38) Up From $(0.69) YoY, Sales $875.000K Up From $749.000K YoY

Biomerica (NASDAQ:BMRA) reported quarterly losses of $(0.38) per share. This is a 44.93 percent increase over losses of $(0.69) per share from the same period last year. The company reported $875.000 thousand in sales

Deal Dispatch: Carets Corp Explores Strategic Alternatives, nVent Electric Buys Maverick Power for $1.75 Billion, BioXcel Bankruptcy

Major M&A deals this week include: The Descartes Systems buys Tai, KKR nabs Ci FLAVORS, Skimmer Acquires Pool Builder Geek and Poologics.

Biomerica shares are trading higher after the company announced that it has entered into definitive agreements with institutional and individual investors for a private placement of 1,393,705 unregistered shares of the company’s common stock at a price of $1.60 per share.